Ambu A/S | Colonoscopy Guidance System of the year in Europe 2025

MedTech Outlook Magazine

Ambu A/S
Improving Patient Care

Britt Meelby Jensen, Ambu A/S | Medical Tech Outlook | Colonoscopy Guidance System of the year in EuropeBritt Meelby Jensen, CEO
Hospitals today are facing increasing procedure demand and point-of-care expansion. At the same time, they are experiencing enhanced reprocessing requirements driven by FDA recommendations and new standards and guidelines.

The new guidelines recommend moving to sterilization for high-risk scopes such as bronchoscopes, duodenoscopes, ureteroscopes, and cystoscopes. This makes reprocessing more timeconsuming and expensive, and due to staff shortages and higher staff turnover, maintaining compliance also becomes a cumbersome affair.

Enter Ambu A/S.

By providing a single-use option, Ambu helps customers improve their workflow, efficiency, and productivity for better patient care while eliminating the risk of cross-contamination. The company creates flexibility for customers to structure care delivery and procedure scheduling much more efficiently by eliminating the need for reprocessing.

“We free up resources in reprocessing that can be reallocated to other more value-adding patient care activities. In the current environment of severe staffing shortages this has tremendous value,” says Britt Meelby Jensen, the CEO of Ambu.

Ambu enables customers to move from a CAPEX-driven to an OPEX-driven endoscopy revenue model. Its singleuse endoscopy allows hospitals to move from a primarily fixed-cost model to a variable-cost model where the cost of endoscopy varies with activity and procedural volume. This gives hospitals a much more predictable cost model that is easily scalable.

As the pioneer of single-use endoscopy, Ambu is the only company that offers a comprehensive single-use endoscopy platform supporting multiple clinical specialties. The company has a unique modular innovation model, which enables sharing of technology and components across endoscopy specialties. This results in shorter development cycles for new products.
Ambu introduced the first single-use endoscope (aScope) to the market back in 2009. Due to the limitations of the technology at the time (CMOS image sensor), the initial focus was on simpler endoscopy procedures such as airway management. However, the performance and image quality improved and with the release of Ambu’s third-generation bronchoscope in 2013, the company was able to address bronchoscopies in the ICU and OR.

This year Ambu released aScope 5 Broncho, which is the first single-use bronchoscope designed for the advanced needs of interventional pulmonology, requiring high-performance functionality and imaging. The product performs better than the leading reusable bronchoscopes in some areas. Ambu has successfully expanded into several other clinical endoscopy areas, such as ENT, Urology and GI. The company has the largest pipeline of any single-use endoscopy company and will continue to invest in new technologies such as advanced image processing to further enhance the performance of its singleuse endoscope. As the leading singleuse endoscopy company, Ambu has a significantly larger scale compared to competitors, including dual continent manufacturing for optimal supply chain security.

  • Through Ambu’s vision, we are able to provide the broadest specialty portfolio – impacting health care providers in nearly a dozen treatment and therapeutic areas and allowing workflows across the hospital to be improved


Recently, one of Ambu’s newest innovations, the aScope 4 Cysto, was featured in peer-reviewed, high-volume research. The study from Assmus showed a dramatic cost savings of nearly $40,000 annually in going from reusable to single-use – but importantly, due to “improvements,” healthcare providers recommended making Ambu’s singleuse the standard, with a reusable as a backup. Additionally, in late 2021, in research presented by Dr. Hudson Garrett at the annual CHEST conference for pulmonologists, data showed that when comparing outcomes of patients receiving care with single-use bronchoscopes versus those receiving care with reusable bronchoscopes, the sterile, single-use population set saw a 53 percent reduction in quality metricimpacting readmissions. This implies that sterile, single-use equipment that is ready when the patient needs the care can have a significant impact on hospital costs, penalty avoidance, and quality metric standings.

“Through Ambu’s vision, we are able to provide the broadest specialty portfolio – impacting health care providers in nearly a dozen treatment and therapeutic areas and allowing workflows across the hospital to be improved,” says Jensen.

Colonoscopy Guidance System Info

Q1

What makes Ambu A/S recognized in colonoscopy guidance systems?

Ambu A/S has developed a strong reputation through its focus on advancing visualization and procedural support technologies for healthcare environments. Its work in colonoscopy guidance systems reflects an emphasis on clinical usability, imaging performance and procedural efficiency within gastrointestinal care settings. The company supports healthcare professionals by developing technologies designed to improve navigation, visualization and workflow consistency during endoscopic procedures. Attention to product functionality and clinical practicality also contributes to more efficient procedural experiences. This innovation-focused approach positions Ambu A/S as a recognized contributor within modern endoscopy technology.

Q2

How does Ambu A/S support healthcare professionals performing colonoscopy procedures?

Colonoscopy procedures require clear visualization, dependable device performance and efficient procedural workflows. Ambu A/S addresses these needs through colonoscopy guidance systems developed to support procedural confidence and clinical efficiency. The company’s technologies are designed to help healthcare professionals maintain better procedural visibility and operational control during gastrointestinal examinations. Its focus on usability also supports smoother interaction between clinical teams and endoscopic equipment throughout procedures. This combination of technology integration and workflow support contributes to more consistent clinical experiences.

Q3

Why are colonoscopy guidance systems important in gastrointestinal care?

Effective gastrointestinal procedures depend on accurate visualization and dependable procedural support technologies. Ambu A/S strengthens clinical capabilities through colonoscopy guidance systems designed to support procedural accuracy and healthcare efficiency. Advanced guidance technologies help healthcare professionals improve navigation and maintain clearer visualization during examinations. The company’s solutions also contribute to better workflow coordination within clinical environments where procedural consistency is important. This level of technological support becomes increasingly valuable as healthcare organizations prioritize efficiency and high-quality patient care outcomes.

Q4

How does Ambu A/S approach innovation in endoscopy technology?

Medical technology development requires continuous attention to usability, clinical needs and procedural performance. Ambu A/S incorporates these priorities into its colonoscopy guidance systems by focusing on practical innovation and healthcare-focused product development. The company works to improve procedural experiences through technologies that support better visualization and streamlined operation during gastrointestinal procedures. Its emphasis on clinically relevant design also helps healthcare professionals integrate advanced tools more effectively into existing workflows. This innovation-driven strategy strengthens Ambu A/S’s position within the endoscopy technology sector.

Q5

What role does usability play in Ambu A/S’s colonoscopy guidance systems?

Healthcare technologies must support efficient operation while maintaining reliability in demanding clinical settings. Ambu A/S addresses these expectations through colonoscopy guidance systems designed with attention to workflow integration and user interaction. The company focuses on creating solutions that help clinical teams operate equipment efficiently while supporting procedural consistency and patient care objectives. Its usability-centered approach also contributes to smoother procedural coordination within healthcare environments. This focus on practical functionality enhances the value of Ambu A/S’s endoscopy-related technologies.

Q6

Why is Ambu A/S relevant to today’s healthcare technology market?

Healthcare providers continue to seek technologies that improve procedural efficiency, visualization quality and clinical workflow support. Ambu A/S responds to these evolving expectations through colonoscopy guidance systems designed for modern gastrointestinal care environments. Its continued relevance comes from maintaining a strong focus on innovation, clinical usability and procedural performance within endoscopy applications. The company’s ability to combine advanced technology with healthcare-focused design helps support changing clinical demands and operational priorities. This combination of technical expertise and procedural understanding positions Ambu A/S as an important contributor within the medical technology industry.

Colonoscopy Guidance System of the year in Europe – 2025

Company
Ambu A/S

Management
Britt Meelby Jensen, CEO

Description
By providing a single-use option, Ambu helps customers improve their workflow, efficiency and productivity while improving patient care while eliminating the risk of cross contamination. The company creates flexibility for customers to structure care delivery and procedure scheduling much more efficiently by eliminating the need for reprocessing.